Ozempic (semaglutide) is an injectable medication that mimics a natural hormone called GLP-1 (glucagon-like peptide-1), which helps regulate blood sugar levels, slows digestion, and reduces appetite. Initially approved by the FDA in 2017 for type 2 diabetes, it was later approved under a different brand name, Wegovy, for chronic weight management in obese or overweight adults. While the two drugs contain the same active ingredient, Ozempic is sometimes used off-label for wei